|
|
1.
|
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. MedStar authors:
Year: 2022
Citation: - International Journal of Molecular Sciences. 23(4), 2022 Feb 20.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Alobaidi R, Carney B, Clark H, Dougherty R, Haribabu Y, Kuo LW, Rosenthal DS, Simbulan-Rosenthal CM, Sykora P, Vakili S
|
|
|
2.
|
Assessing Factor V Antigen and Degradation Products in Burn and Trauma Patients. MedStar authors:
- Brummel-Ziedins, Kathleen E
- Carney, Bonnie C
- Keyloun, John
- Shupp, Jeffrey W
Year: 2022
Citation:
- Journal of Surgical Research. 274:169-177, 2022 06.
- Journal of Surgical Research. 274:169-177, 2022 Jun.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Firefighters' Burn and Surgical Research Laboratory
- MedStar General Surgery Residency
- MedStar Georgetown University Hospital/MedStar Washington Hospital Center
- Surgery/Burn Services
Medline publication type:
All authors: - Bourne DE, Bravo MC, Brummel-Ziedins KE, Carney BC, Freeman K, Kaye MD, Keyloun JW, Le TD, Mann KG, Orfeo T, Pusateri AE, Shupp JW, SYSCOT Study Group
|
